marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-24-2024
West Pharmaceutical Services Balance Sheet 2011-2024 | WST
Annual Balance Sheet West Pharmaceutical Services
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-763 M | -672 M | -544 M | -352 M | -182 M | -141 M | -38.9 M | 25.6 M | 23.6 M | 81.4 M | 144 M | 250 M | 258 M |
Long Term Debt |
72.8 M | 207 M | 209 M | 253 M | 255 M | 196 M | 197 M | 226 M | 229 M | 310 M | 371 M | 379 M | 299 M |
Long Term Debt Current |
17.7 M | 16 M | 9.3 M | 10.1 M | 9.6 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 427 M | 299 M | 303 M | 358 M | 357 M | 462 M | 528 M | 573 M | 501 M |
Total Current Liabilities |
672 M | 519 M | 594 M | 503 M | 342 M | 284 M | 280 M | 241 M | 314 M | 252 M | 237 M | 262 M | 243 M |
Total Liabilities |
948 M | 932 M | 978 M | 939 M | 768 M | 583 M | 583 M | 599 M | 671 M | 714 M | 765 M | 835 M | 744 M |
Deferred Revenue |
41.7 M | 57.3 M | 48.7 M | 51 M | 27.5 M | 25.5 M | 18.4 M | 13.2 M | 14.4 M | 13.3 M | - | - | - |
Retained Earnings |
3.52 B | 2.99 B | 2.46 B | 1.85 B | 1.55 B | 1.35 B | 1.18 B | 1.07 B | 965 M | 902 M | 805 M | 720 M | 664 M |
Total Assets |
3.83 B | 3.62 B | 3.31 B | 2.79 B | 2.34 B | 1.98 B | 1.86 B | 1.72 B | 1.7 B | 1.67 B | 1.67 B | 1.56 B | 1.4 B |
Cash and Cash Equivalents |
854 M | 894 M | 763 M | 616 M | 439 M | 337 M | 236 M | 203 M | 275 M | 255 M | 230 M | 162 M | 91.8 M |
Book Value |
2.88 B | 2.68 B | 2.34 B | 1.85 B | 1.57 B | 1.4 B | 1.28 B | 1.12 B | 1.02 B | 957 M | 906 M | 729 M | 655 M |
Total Shareholders Equity |
2.88 B | 2.68 B | 2.34 B | 1.85 B | 1.57 B | 1.4 B | 1.28 B | 1.12 B | 1.02 B | 957 M | 906 M | 729 M | 655 M |
All numbers in USD currency
Quarterly Balance Sheet West Pharmaceutical Services
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
203 M | 72.9 M | 72.8 M | 72.8 M | 152 M | 206 M | 206 M | 207 M | 207 M | - | 208 M | 209 M | 210 M | 252 M | 252 M | 253 M | 253 M | 253 M | 253 M | 255 M | 255 M | 255 M | 255 M | 196 M | 196 M | 196 M | 196 M | 197 M | 197 M | 197 M | 197 M | 226 M | 226 M | 226 M | 226 M | 229 M | 229 M | 229 M | 229 M | 308 M | 310 M | 310 M | 310 M | 371 M | 371 M | 371 M | 371 M | 379 M | 379 M | 379 M | 379 M | 299 M | 299 M | 299 M | 299 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
923 M | 913 M | 922 M | 948 M | 886 M | 923 M | 947 M | 932 M | 846 M | - | 968 M | 978 M | 940 M | 901 M | 911 M | 939 M | 939 M | 939 M | 939 M | 768 M | 768 M | 768 M | 768 M | 583 M | 583 M | 583 M | 583 M | 583 M | 583 M | 583 M | 583 M | 599 M | 599 M | 599 M | 599 M | 671 M | 671 M | 671 M | 671 M | 713 M | 714 M | 714 M | 714 M | 765 M | 765 M | 765 M | 765 M | 835 M | 835 M | 835 M | 835 M | 744 M | 744 M | 744 M | 744 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 48.7 M | - | - | - | 51 M | - | - | - | 27.5 M | - | - | - | 25.5 M | - | - | - | 1.5 M | - | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
3.86 B | 3.72 B | 3.62 B | 3.52 B | 3.42 B | 3.25 B | 3.11 B | 2.99 B | 2.91 B | - | 2.62 B | 2.46 B | 2.34 B | 2.16 B | 1.99 B | 1.85 B | 1.85 B | 1.85 B | 1.85 B | 1.55 B | 1.55 B | 1.55 B | 1.55 B | 1.35 B | 1.35 B | 1.35 B | 1.35 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.07 B | 1.07 B | 1.07 B | 1.07 B | 965 M | 965 M | 965 M | 965 M | 902 M | 902 M | 902 M | 902 M | 805 M | 805 M | 805 M | 805 M | 720 M | 720 M | - | - | 664 M | - | - | - |
Total Assets |
3.68 B | 3.49 B | 3.6 B | 3.83 B | 3.75 B | 3.67 B | 3.72 B | 3.62 B | 3.32 B | - | 3.29 B | 3.31 B | 3.14 B | 2.93 B | 2.74 B | 2.79 B | 2.79 B | 2.79 B | 2.79 B | 2.34 B | 2.34 B | 2.34 B | 2.34 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B | 1.86 B | 1.86 B | 1.86 B | 1.86 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 1.7 B | 1.7 B | 1.7 B | 1.7 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.56 B | 1.56 B | 1.56 B | 1.56 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B |
Cash and Cash Equivalents |
491 M | 446 M | 602 M | 854 M | 899 M | 796 M | 886 M | 894 M | 729 M | 718 M | 668 M | 763 M | 688 M | 576 M | 484 M | 616 M | 616 M | 616 M | 616 M | 439 M | 439 M | 439 M | 439 M | 337 M | 337 M | 337 M | 337 M | 236 M | 236 M | 236 M | 236 M | 203 M | 203 M | 203 M | 203 M | 275 M | 275 M | 275 M | 275 M | 255 M | 255 M | 255 M | 255 M | 230 M | 230 M | 230 M | 230 M | 162 M | 162 M | 162 M | 162 M | 91.8 M | 91.8 M | 91.8 M | 91.8 M |
Book Value |
2.75 B | 2.58 B | 2.68 B | 2.88 B | 2.87 B | 2.75 B | 2.78 B | 2.68 B | 2.47 B | - | 2.33 B | 2.34 B | 2.2 B | 2.03 B | 1.83 B | 1.85 B | 1.85 B | 1.85 B | 1.85 B | 1.57 B | 1.57 B | 1.57 B | 1.57 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.28 B | 1.28 B | 1.28 B | 1.28 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 957 M | 957 M | 957 M | 957 M | 905 M | 906 M | 906 M | 906 M | 729 M | 729 M | 729 M | 729 M | 655 M | 655 M | 655 M | 655 M |
Total Shareholders Equity |
2.75 B | 2.58 B | 2.68 B | 2.88 B | 2.87 B | 2.75 B | 2.78 B | 2.68 B | 2.47 B | 2.42 B | 2.33 B | 2.34 B | 2.2 B | 2.03 B | 1.83 B | 1.85 B | 1.85 B | 1.85 B | 1.85 B | 1.57 B | 1.57 B | 1.57 B | 1.37 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.28 B | 1.28 B | 1.28 B | 1.28 B | 1.12 B | 1.12 B | 1.12 B | 1.12 B | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 957 M | 957 M | 957 M | 957 M | 906 M | 906 M | 906 M | 906 M | 729 M | 729 M | 729 M | 729 M | 655 M | 655 M | 655 M | 655 M |
All numbers in USD currency